Infant Lutein Surpasses CN¥ 800M as Eye Health Fears Rise

Executive Summary

China's infant lutein market exceeded CN¥ 800 million in sales value with approximately 4.73 million units sold in 2024, establishing itself as one of the fastest-growing segments in children's nutrition. The category's explosive growth stems from a convergence of rising parental anxiety about children's screen time and myopia rates, a dominant gummy formulation that commands 82.8% market share, and a uniquely balanced tri-platform distribution where Taobao/Tmall (天猫), JD.com (京东), and Douyin (抖音) each hold roughly 30% of sales. This analysis examines seasonal sales patterns, brand competition, price segmentation, and product formulation trends shaping this rapidly evolving market.

Tri-Platform Balance Distinguishes Lutein from Other Supplements

The infant lutein market stands apart from most supplement categories through its remarkably balanced platform distribution. Where Taobao/Tmall typically dominates Chinese e-commerce supplement sales, lutein purchasing spreads evenly across three major platforms --- each contributing roughly 30% of total sales. This structural characteristic reflects distinct consumer acquisition pathways: search-driven purchasing on Taobao/Tmall, trust-driven buying on JD.com, and content-driven conversion on Douyin.

Monthly sales data reveals clear seasonality with a pronounced October-November peak driven by the Double 11 shopping festival. Taobao/Tmall posted its highest monthly sales of CN¥ 45.8 million in October, suggesting strong pre-festival purchasing behavior. JD.com achieved its peak of CN¥ 39.0 million during June's 6.18 festival, while Douyin reached CN¥ 30.2 million in July, reflecting the platform's summer campaign activity when children spend more time on screens during school break.

Infant lutein market peaks in October-November during promotional festivals, with balanced tri-platform distribution

One Brand Dominates, but the Market Remains Accessible

The competitive landscape features a single dominant leader with ~CN¥ 344 million in 2024 sales and +518.3% year-on-year (YoY) growth, followed by a cluster of challengers ranging from CN¥ 16 million to CN¥ 101.5 million. The wide dispersion of growth rates --- from +14.4% to +578.2% --- indicates that the infant lutein market has not yet consolidated, and multiple brands achieved rapid scale in 2024 through differentiated entry strategies.

Inne leads with CN¥ 344 million in sales, while smaller brands achieve explosive growth rates

Douyin's Mid-Range Pricing Reflects Content Commerce Dynamics

Price segmentation varies meaningfully across platforms, reflecting distinct consumer profiles and purchasing behaviors. On Douyin, the CN¥ 100-200 price segment dominates with 48.2% of sales, establishing it as the mainstream price point for content-commerce-driven purchases. The CN¥ 500+ segment commands a notable 22.7% share, primarily consisting of multi-product bundle packs that combine lutein with complementary nutrients like calcium or DHA.

CN¥ 100-200 range captures 48.2% of Douyin lutein sales, with premium bundles above CN¥ 500 at 22.7%

Gummies Command 82.8% as Format War Ends Before It Begins

Unlike the ongoing dosage form competition in adult supplements, the infant lutein market has already reached a decisive verdict. Gummy formulations command 82.8% market share, an overwhelming majority that reflects the format's success in solving the core challenge of children's supplement adherence. The pleasant taste and playful format encourages the consistent daily consumption essential for lutein's eye-protective benefits.

Gummy formulations command 82.8% market share, establishing dominance in children's supplement delivery

Key Takeaways

• China's infant lutein market exceeded CN¥ 800 million in 2024 with 4.73 million units sold, fueled by rising parental anxiety about children's screen time and myopia.
• The market leader achieved ~CN¥ 344 million in sales with +518.3% YoY growth, but the category remains accessible --- eight other top-10 brands grew between +14.4% and +578.2%.
• Tri-platform balance (~30% each for Taobao/Tmall, JD.com, and Douyin) distinguishes lutein from most supplement categories where one platform typically dominates.
• 48.2% of Douyin sales concentrate in the CN¥ 100-200 range, while Taobao/Tmall skews premium with 27.1% in the CN¥ 400-500 segment.
• Gummy formulations command 82.8% market share, making format innovation within gummies more strategically valuable than dosage form diversification.
• Seasonal peaks in October-November (Double 11) and June (6.18) create concentrated marketing windows, with July offering a Douyin-specific content opportunity tied to summer screen time concerns.

About the Data

This analysis draws on Moojing Market Intelligence data covering China's infant lutein market across Taobao/Tmall, JD.com, and Douyin for the full year 2024. Moojing tracks 400,000+ brands across 30+ e-commerce platforms, representing 58-65% of China's online retail GMV. For full methodology and additional segment-level insights across infant nutrition, children's vision health, and supplement formulation trends, see the complete Child Health & Wellness whitepaper.

Moojing Market Intelligence (魔镜洞察) provides e-commerce analytics and consumer insights across 20+ countries. For inquiries, contact [email protected].